HUE044048T2 - Eljárás tienopirimidin származék elõállítására - Google Patents

Eljárás tienopirimidin származék elõállítására

Info

Publication number
HUE044048T2
HUE044048T2 HUE13779938A HUE13779938A HUE044048T2 HU E044048 T2 HUE044048 T2 HU E044048T2 HU E13779938 A HUE13779938 A HU E13779938A HU E13779938 A HUE13779938 A HU E13779938A HU E044048 T2 HUE044048 T2 HU E044048T2
Authority
HU
Hungary
Prior art keywords
production method
thienopyrimidine derivative
thienopyrimidine
derivative
production
Prior art date
Application number
HUE13779938A
Other languages
English (en)
Inventor
Koichiro Fukuoka
Kazuhiro Miwa
Tsuyoshi Sasaki
Fumiya Komura
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Publication of HUE044048T2 publication Critical patent/HUE044048T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
HUE13779938A 2012-09-28 2013-09-27 Eljárás tienopirimidin származék elõállítására HUE044048T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012217679 2012-09-28

Publications (1)

Publication Number Publication Date
HUE044048T2 true HUE044048T2 (hu) 2019-09-30

Family

ID=49448235

Family Applications (2)

Application Number Title Priority Date Filing Date
HUE13779938A HUE044048T2 (hu) 2012-09-28 2013-09-27 Eljárás tienopirimidin származék elõállítására
HUE18185835A HUE059077T2 (hu) 2012-09-28 2013-09-27 1-(4-1-(2,6-difluorbenzil)-5-dimetilaminometil-3-(6-metoxipiridazin-3-il)-2,4 -dioxo-1,2,3,4-tetrahidrotieno(2,3-D)-pirimidin-6-il)fenil)-3-metoxikarbamid kristályos alakja

Family Applications After (1)

Application Number Title Priority Date Filing Date
HUE18185835A HUE059077T2 (hu) 2012-09-28 2013-09-27 1-(4-1-(2,6-difluorbenzil)-5-dimetilaminometil-3-(6-metoxipiridazin-3-il)-2,4 -dioxo-1,2,3,4-tetrahidrotieno(2,3-D)-pirimidin-6-il)fenil)-3-metoxikarbamid kristályos alakja

Country Status (20)

Country Link
US (8) US9758528B2 (hu)
EP (3) EP4119564A1 (hu)
JP (1) JP6250564B2 (hu)
CN (3) CN113372358A (hu)
AR (1) AR092707A1 (hu)
CA (1) CA2881132C (hu)
CY (1) CY1121641T1 (hu)
DK (2) DK2900675T3 (hu)
ES (2) ES2913753T3 (hu)
HR (2) HRP20220622T1 (hu)
HU (2) HUE044048T2 (hu)
LT (2) LT2900675T (hu)
PL (2) PL2900675T3 (hu)
PT (2) PT2900675T (hu)
RS (2) RS63199B1 (hu)
SI (2) SI3415517T1 (hu)
TR (1) TR201906318T4 (hu)
TW (3) TWI663171B (hu)
UY (1) UY35058A (hu)
WO (1) WO2014051164A2 (hu)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE044048T2 (hu) 2012-09-28 2019-09-30 Takeda Pharmaceuticals Co Eljárás tienopirimidin származék elõállítására
SI3263110T1 (sl) 2015-02-26 2023-09-29 Takeda Pharmaceutical Company Limited Tableta, ki vsebuje derivat metoksisečnine in delce manitola
JP7062673B2 (ja) 2016-09-30 2022-05-06 ミオバント サイエンシズ ゲーエムベーハー 前立腺がんの治療
JP7043503B2 (ja) 2016-09-30 2022-03-29 ミオバント サイエンシズ ゲーエムベーハー 子宮筋腫及び子宮内膜症を治療する方法
KR102516017B1 (ko) * 2016-11-14 2023-03-30 지앙수 헨그루이 파마슈티컬스 컴퍼니 리미티드 GnRH 수용체 길항제의 결정질 형태 및 그의 제조 방법
KR20200027481A (ko) 2017-06-05 2020-03-12 옵스에파 에스에이 자궁내막증의 치료를 위한 고나도트로핀 방출호르몬 길항제 투약요법
CN107188855A (zh) * 2017-07-14 2017-09-22 常州工程职业技术学院 一种3‑氨基‑6甲氧基哒嗪的制备方法
WO2019178304A1 (en) 2018-03-14 2019-09-19 Teva Pharmaceuticals International Gmbh Solid state forms of relugolix
EP3666776A1 (en) 2018-12-11 2020-06-17 Sandoz AG Hydrate of a gonadotropin-releasing hormone receptor antagonist
WO2020230094A1 (en) * 2019-05-15 2020-11-19 Dr. Reddy’S Laboratories Limited Amorphous and crystalline forms of relugolix
CN110194776B (zh) * 2019-06-27 2021-05-28 四川伊诺达博医药科技有限公司 一种瑞卢戈利的合成方法
WO2021018105A1 (en) * 2019-07-29 2021-02-04 Sunshine Lake Pharma Co., Ltd. Substituted pyrimidinedione compounds and uses thereof
BR112022001002A2 (pt) * 2019-08-02 2022-04-12 Johnson Matthey Plc Solvato de dmf, forma a, forma c, processos para a preparação do solvato de dmf, para a preparação da forma a de relugolix anidra, para a preparação da forma b de relugolix anidra e para a preparação da forma c de relugolix anidra, composição farmacêutica, e, método de tratamento de doença
CN112321602A (zh) * 2019-08-05 2021-02-05 苏州鹏旭医药科技有限公司 一种瑞卢戈利药物中间体的制备方法
CN112390812A (zh) * 2019-08-14 2021-02-23 苏州鹏旭医药科技有限公司 瑞卢戈利化合物的晶型和无定型固体及其制备方法
CN112771052B (zh) * 2019-08-21 2023-04-07 深圳仁泰医药科技有限公司 促性腺素释放激素拮抗剂的晶型及其制备方法和用途
CN115279769A (zh) * 2019-10-10 2022-11-01 梦欧文科学有限责任公司 N-(4-(1-(2,6-二氟苄基)-5-((二甲基氨基)甲基)-3-(6-甲氧基-3-哒嗪基)-2,4-二氧代-1,2,3,4-四氢噻吩并[2,3-d]嘧啶-6-基)苯基)-n’-甲氧基脲的结晶形式
EP4041738A1 (en) * 2019-10-10 2022-08-17 Myovant Sciences GmbH Crystalline solvated forms of n-(4-(1-(2,6-difluorobenzyl)-5- ((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4- tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-n'-methoxyurea
CN112745304A (zh) * 2019-10-29 2021-05-04 上海度德医药科技有限公司 一种Relugolix的制备方法及中间体化合物
CN111423452B (zh) * 2020-03-26 2023-08-22 江西青峰药业有限公司 瑞卢戈利的中间体及其制备方法和应用
CN113444105A (zh) * 2020-03-27 2021-09-28 南京海润医药有限公司 一种Relugolix的制备方法
CN111333633B (zh) * 2020-04-01 2023-10-20 江西科睿药业有限公司 一种瑞卢戈利的中间体化合物及其制备方法和用途
CN111574534B (zh) * 2020-05-25 2021-06-04 东莞市东阳光新药研发有限公司 苯基取代的噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮类化合物及其用途
AR122175A1 (es) 2020-05-29 2022-08-24 Myovant Sciences Gmbh Formas de dosificación oral sólidas de combinación de antagonistas de la hormona liberadora de gonadotropina
US11655256B1 (en) 2020-11-06 2023-05-23 Macfarlan Smith Limited Processes for making a solid-state form of relugolix
WO2022101303A1 (en) 2020-11-11 2022-05-19 Myovant Sciences Gmbh Methods of administering relugolix
CN112552312B (zh) * 2020-12-07 2022-08-05 杭州科巢生物科技有限公司 一种瑞卢戈利或其盐的合成方法
CN114685468A (zh) * 2020-12-25 2022-07-01 成都硕德药业有限公司 用于治疗子宫肌瘤的药物的中间体化合物及其制备方法
CN113620972A (zh) * 2021-02-02 2021-11-09 奥锐特药业(天津)有限公司 瑞卢戈利新晶型及其制备方法
CN114907370B (zh) 2021-02-10 2023-11-03 奥锐特药业(天津)有限公司 高纯度的噻吩并嘧啶化合物及其制备方法
CN115073491A (zh) * 2021-03-12 2022-09-20 上海医药工业研究院 一种瑞卢戈利中间体、其制备方法及其应用
WO2022214645A1 (en) 2021-04-09 2022-10-13 Farmhispania Group, S.L. Processes and intermediates for the preparation of relugolix
CN115594688B (zh) * 2021-06-28 2023-11-17 成都倍特药业股份有限公司 瑞卢戈利中间体的制备方法
WO2023066941A1 (en) * 2021-10-18 2023-04-27 Myovant Sciences Gmbh Crystalline form of an ethanol solvate of n-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-n'-methoxyurea
CN114230576A (zh) * 2021-12-21 2022-03-25 伊诺药物研究(南京)有限公司 一种瑞卢戈利的制备方法
WO2023119333A1 (en) * 2021-12-25 2023-06-29 Dr. Reddy’S Laboratories Limited Process for preparation of relugolix and its intermediates
CN114409629B (zh) * 2022-02-22 2023-12-29 浙江科聚生物医药有限公司 一种高纯度Relugolix关键中间体的制备方法及应用
CN114790189B (zh) * 2022-02-24 2023-06-09 海化生命(厦门)科技有限公司 瑞卢戈利中间体的制备方法
CN114755320A (zh) * 2022-03-17 2022-07-15 南京方生和医药科技有限公司 一种3-氨基-6-甲氧基哒嗪有关物质的检测方法
WO2023194924A1 (en) * 2022-04-08 2023-10-12 Glenmark Life Sciences Limited Process for preparation of relugolix
CN114621249B (zh) * 2022-04-27 2024-01-26 江苏慧聚药业股份有限公司 瑞卢戈利关键中间体的制备
WO2023214935A1 (en) * 2022-05-05 2023-11-09 Scinopharm Taiwan, Ltd. Process for preparing relugolix and intermediates thereof
CN115594689B (zh) * 2022-07-14 2024-03-19 江西同和药业股份有限公司 一种瑞卢戈利中间体、一种瑞卢戈利的合成方法
CN117285506A (zh) * 2022-07-14 2023-12-26 江西同和药业股份有限公司 一种瑞卢戈利中间体及其制备方法
CN115417883A (zh) * 2022-09-16 2022-12-02 浙江科聚生物医药有限公司 一种瑞卢戈利的晶型及其制备方法
WO2024069492A1 (en) 2022-09-29 2024-04-04 Macfarlan Smith Limited Processes for the preparation and manufacture of relugolix
CN115650950A (zh) * 2022-11-03 2023-01-31 江西同和药业股份有限公司 一种瑞卢戈利中间体及其制备方法以及一种酰胺缩合方法
CN115650965B (zh) * 2022-12-26 2023-03-31 南京威凯尔生物医药科技有限公司 一种瑞卢戈利关键中间体的制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5116436B1 (hu) * 1971-05-31 1976-05-24
EP0237289A3 (en) * 1986-03-14 1988-07-27 Takeda Chemical Industries, Ltd. Pyrazolo [3,4-d] pyrimidine derivatives, their production and use
JP2859791B2 (ja) 1992-01-31 1999-02-24 吉富製薬株式会社 4−ブロモメチルビフェニル化合物の製造法
US5312958A (en) 1992-01-31 1994-05-17 Takeda Chemical Industries, Ltd. Process for producing 4-bromomethylbiphenyl compounds
JPH10298156A (ja) 1997-04-28 1998-11-10 Nippon Nohyaku Co Ltd 置換ハロメチルフェニルカルバミド酸エステル類の製造方法
TWI225863B (en) 1999-03-24 2005-01-01 Takeda Chemical Industries Ltd Thienopyrimidine compounds, their production and use
RU2233284C2 (ru) 1999-03-24 2004-07-27 Такеда Кемикал Индастриз, Лтд. Тиенопиримидиновые производные, способ их получения, фармацевтическая композиция и способ антагонизации гонадотропин-рилизинг гормона
JP2001316391A (ja) * 2000-02-29 2001-11-13 Takeda Chem Ind Ltd チエノピリミジン誘導体の製造法
CN1539836A (zh) 2000-02-29 2004-10-27 武田药品工业株式会社 制备噻吩并嘧啶衍生物的方法
GB2361917A (en) * 2000-05-04 2001-11-07 Astrazeneca Ab Novel thieno[2,3-d]pyrimidinediones
JP2002068044A (ja) 2000-09-04 2002-03-08 Yamaha Motor Co Ltd 自動二輪車用ハンドルシート
JP2002088044A (ja) 2000-09-14 2002-03-27 Sumitomo Seika Chem Co Ltd 4’−ブロモメチル−2−シアノビフェニルの製造方法
DE60207280T2 (de) 2001-09-04 2006-05-18 Akzo Nobel N.V. GLYCINSUBSTITUIERTE THIENO[2,3-d]PYRIMIDINE MIT KOMBINIERTER LH- UND FSH-AGONISTISCHER WIRKUNG
US7569570B2 (en) * 2002-01-30 2009-08-04 Takeda Pharmaceutical Company Limited Thienopyrimidines, process for preparing the same and use thereof
AU2003303269A1 (en) 2002-12-20 2004-07-14 Koninklijke Philips Electronics N.V. Enhancing video images depending on prior image enhancements
ES2217956B1 (es) 2003-01-23 2006-04-01 Almirall Prodesfarma, S.A. Nuevos derivados de 4-aminotieno(2,3-d)pirimidin-6-carbonitrilo.
CN101153042A (zh) 2003-01-29 2008-04-02 武田药品工业株式会社 噻吩并嘧啶化合物及其用途
US7947691B2 (en) * 2004-07-21 2011-05-24 Athersys, Inc. Cyclic n-hydroxy imides as inhibitors of flap endonuclease and uses thereof
RU2007115517A (ru) * 2004-10-25 2008-10-27 Нихон Нохияку Ко. Гербицидная композиция для пастбищно-выпасного хозяйства на холмах и способ борьбы с сорняками
CN101272806A (zh) * 2005-07-22 2008-09-24 武田药品工业株式会社 过早排卵抑制剂
EP2329823A4 (en) 2008-09-03 2013-04-03 Takeda Pharmaceutical METHOD FOR IMPROVING CAPACITY OF PREPARATION TO BE ABSORBED AND PREPARATION WHICH CAPACITY TO BE ABSORBED IS IMPROVED
DK2678327T3 (en) * 2011-02-23 2016-12-12 Lupin Ltd Heteroaryl derivatives which ALFA7 nAChR modulators
JP2012217679A (ja) 2011-04-11 2012-11-12 Okumura Yu-Ki Co Ltd パチンコ遊技機
HUE044048T2 (hu) 2012-09-28 2019-09-30 Takeda Pharmaceuticals Co Eljárás tienopirimidin származék elõállítására
SI3263110T1 (sl) 2015-02-26 2023-09-29 Takeda Pharmaceutical Company Limited Tableta, ki vsebuje derivat metoksisečnine in delce manitola

Also Published As

Publication number Publication date
US10150778B2 (en) 2018-12-11
US20190055261A1 (en) 2019-02-21
RS63199B1 (sr) 2022-06-30
EP4119564A1 (en) 2023-01-18
LT2900675T (lt) 2019-05-27
CN104703992A (zh) 2015-06-10
CA2881132C (en) 2020-11-24
US20170210753A1 (en) 2017-07-27
CA2881132A1 (en) 2014-04-03
CN109053766A (zh) 2018-12-21
CN104703992B (zh) 2019-03-05
EP2900675A2 (en) 2015-08-05
TW201906847A (zh) 2019-02-16
US11053257B2 (en) 2021-07-06
US20150266891A1 (en) 2015-09-24
US11731983B2 (en) 2023-08-22
TWI663171B (zh) 2019-06-21
HUE059077T2 (hu) 2022-11-28
ES2724206T3 (es) 2019-09-09
TWI641611B (zh) 2018-11-21
JP2015532262A (ja) 2015-11-09
PT2900675T (pt) 2019-05-28
TW201808962A (zh) 2018-03-16
PL2900675T3 (pl) 2019-08-30
CN109053766B (zh) 2021-06-22
TR201906318T4 (tr) 2019-05-21
PT3415517T (pt) 2022-05-13
EP3415517B1 (en) 2022-04-20
HRP20220622T1 (hr) 2022-06-24
US10464945B2 (en) 2019-11-05
US20230212184A1 (en) 2023-07-06
CY1121641T1 (el) 2020-07-31
LT3415517T (lt) 2022-06-10
US20220204525A1 (en) 2022-06-30
US20200361953A1 (en) 2020-11-19
US10544160B2 (en) 2020-01-28
AR092707A1 (es) 2015-04-29
US20220135585A1 (en) 2022-05-05
US9758528B2 (en) 2017-09-12
JP6250564B2 (ja) 2017-12-20
EP2900675B1 (en) 2019-03-06
DK3415517T3 (da) 2022-05-30
WO2014051164A3 (en) 2014-05-22
SI2900675T1 (sl) 2019-06-28
TW201418262A (zh) 2014-05-16
EP3415517A1 (en) 2018-12-19
ES2913753T3 (es) 2022-06-06
DK2900675T3 (da) 2019-06-03
RS58703B1 (sr) 2019-06-28
HRP20190729T1 (hr) 2019-06-14
SI3415517T1 (sl) 2022-06-30
TWI602819B (zh) 2017-10-21
UY35058A (es) 2014-04-30
CN113372358A (zh) 2021-09-10
US11795178B2 (en) 2023-10-24
PL3415517T3 (pl) 2022-07-04
WO2014051164A2 (en) 2014-04-03
US20180319816A1 (en) 2018-11-08

Similar Documents

Publication Publication Date Title
RS58703B1 (sr) Metoda proizvodnje derivata tienopirimidina
HUE043865T2 (hu) Többrétegû üvegtáblák elõállítási eljárása
EP2907836A4 (en) METHOD FOR CONTINUOUS PRODUCTION OF A POLYCARBONATE POLYORGANOSILOXAN COPOLYMER
HUE037048T2 (hu) Eljárások 4-cikloalkiloxibenzolszulfonamidok elõállítására
PL2825719T3 (pl) Sposób obsługi odwiertów
SG11201405499QA (en) Method for production of conjugated diolefin
HUE037086T2 (hu) Eljárás alanin aerob elõállítására
GB2504804B (en) Method of making super-hard constructions
EP2913831A4 (en) PROCESS FOR PRODUCING RARE EARTH MAGNET
EP2937328A4 (en) PROCESS FOR PRODUCING ALCOHOL
IL234024A0 (en) A method for making a multi-layered item
PL2931937T3 (pl) Sposób wytwarzania układów nanocząstek metali
HUE041814T2 (hu) Eljárás izoidid elõállítására
GB201220155D0 (en) Method of manufacture
HK1203967A1 (en) Methods of ganglioside production
LU92341B1 (en) Method of producing a shaped component
PT2719682T (pt) Método para preparação contínua de nitrobenzeno
GB201223271D0 (en) Process for production of an alkylmethacrylate
EP2697334A4 (en) PROCESS FOR THE PRODUCTION OF RETAINING AGENTS
EP2871033A4 (en) MANUFACTURING METHOD FOR CEMENT
EP2826805A4 (en) PROCESS FOR THE PRODUCTION OF CONTINUOUS POLYCARBONATE
SG2013085071A (en) Method of producing methionine
EP2832696A4 (en) MAYENITHERSTELLUNGSVERFAHREN
GB201215942D0 (en) Method of treatent
HK1199884A1 (en) Method for producing cereulide and derivative thereof, intermediate for production of cereulide, and cereulide derivative cereulide cereulide cereulide